Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Public ClinicalTrials.gov record NCT07837973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Multi-Center, Dose-Ranging, Phase 2 Study of the Efficacy and Safety of ALV-100 Versus Placebo for Maintenance of Weight Loss in Patients Previously on Semaglutide
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with semaglutide.
Study identification
- NCT ID
- NCT07837973
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2026
- Primary completion
- Aug 23, 2027
- Completion
- Aug 23, 2027
- Last update posted
- Sep 23, 2026
2026 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Birmingham | Birmingham | Alabama | 35294 | Recruiting |
| AMR Clinical | Tempe | Arizona | 85281 | Recruiting |
| Profound Research | Oceanside | California | 92058 | Recruiting |
| Clinical Neuroscience Solutions | Orlando | Florida | 32801 | Recruiting |
| Christie Clinic | Champaign | Illinois | 61822 | Recruiting |
| BRCR Global Louisiana | Gretna | Louisiana | 70053 | Recruiting |
| Profound Research | Farmington Hills | Michigan | 48334 | Recruiting |
| ALSA Research-Manhattan | New York | New York | 10016 | Recruiting |
| TMA Headlands | Wilmington | North Carolina | 28403 | Recruiting |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | Recruiting |
| AMR Clinical | Nashville | Tennessee | 37203 | Recruiting |
| AMR Clinical | South Jordan | Utah | 84095 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07837973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2026 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07837973 live on ClinicalTrials.gov.